These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 15716194
1. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study. Witjes JA, Moonen PM, van der Heijden AG. Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194 [Abstract] [Full Text] [Related]
3. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ, PC B302/01 Study Group. J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283 [Abstract] [Full Text] [Related]
7. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. Ray ER, Chatterton K, Khan MS, Thomas K, Chandra A, O'Brien TS. BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151 [Abstract] [Full Text] [Related]
8. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)? Geavlete B, Multescu R, Georgescu D, Jecu M, Stanescu F, Geavlete P. BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438 [Abstract] [Full Text] [Related]
9. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin. Ray ER, Chatterton K, Khan MS, Chandra A, Thomas K, Dasgupta P, O'Brien TS. BJU Int; 2010 Mar; 105(6):789-94. PubMed ID: 19832725 [Abstract] [Full Text] [Related]
14. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer]. Daniltchenko D, Riedl C, Koenig F, Daha LK, Sachs M, Schnorr D. Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230 [Abstract] [Full Text] [Related]
15. Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride? Gravas S, Efstathiou K, Zachos I, Melekos MD, Tzortzis V. Can J Urol; 2012 Jun; 19(3):6269-73. PubMed ID: 22704312 [Abstract] [Full Text] [Related]
16. Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden. Malmström PU, Hedelin H, Thomas YK, Thompson GJ, Durrant H, Furniss J. Scand J Urol Nephrol; 2009 Jun; 43(3):192-8. PubMed ID: 19330681 [Abstract] [Full Text] [Related]